TokenPost·
Milestone Pharmaceuticals Posts $2.96 Million in Q3 Revenue, Beating Estimate
Its GAAP loss per share was $0.18, 4 cents smaller than estimated.
More news
- TokenPostStablecoin market cap falls to $288.45 billion as Arc grows 20.29%
- TokenPostAnonymous Source Says Huang Called Nvidia CFO 'A Deer in the Headlights'
- Crypto BriefingMANTRA halts new unstaking requests amid Web3Auth and Keplr exploit
- TokenPostCourt Authorizes Seizure or Freeze of More Than $1.2B in Stolen Binance Crypto
- Crypto BriefingJensen Huang reportedly called interim Nvidia CEO Colette Kress ‘a deer in the headlights’
- TokenPostNoodles & Company Shares Rise About 12% After Q3 Results Beat Estimates